349 related articles for article (PubMed ID: 18313119)
1. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
Blana A; Hierl J; Rogenhofer S; Lunz JC; Wieland WF; Walter B; Bach T; Ganzer R
Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
[TBL] [Abstract][Full Text] [Related]
2. Development of bladder outlet obstruction after a single treatment of prostate cancer with high-intensity focused ultrasound: experience with 226 patients.
Netsch C; Pfeiffer D; Gross AJ
J Endourol; 2010 Sep; 24(9):1399-403. PubMed ID: 20804429
[TBL] [Abstract][Full Text] [Related]
3. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
Otsuki H; Sumitomo M; Umeda S; Shirotake S; Tobe M; Ito K; Asano T; Nagakura K; Hayakawa M
Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
[TBL] [Abstract][Full Text] [Related]
4. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
5. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
6. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
Tanaka Y; Masumori N; Itoh N; Furuya S; Ogura H; Tsukamoto T
Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
[TBL] [Abstract][Full Text] [Related]
7. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
[TBL] [Abstract][Full Text] [Related]
8. Residual fraction as a parameter to predict bladder outlet obstruction in men with lower urinary tract symptoms.
Ku JH; Cho SY; Oh SJ
Int J Urol; 2009 Sep; 16(9):739-44. PubMed ID: 19659551
[TBL] [Abstract][Full Text] [Related]
9. Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use.
Ripert T; Azémar MD; Ménard J; Bayoud Y; Messaoudi R; Duval F; Staerman F
Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):132-7. PubMed ID: 20048758
[TBL] [Abstract][Full Text] [Related]
10. [Applying bladder outlet obstruction number to predict bladder outlet obstruction of benign prostatic hyperplasia].
Zhang P; Wu ZJ; Yang Y; Zhang XD
Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1156-9. PubMed ID: 19094679
[TBL] [Abstract][Full Text] [Related]
11. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
12. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
[TBL] [Abstract][Full Text] [Related]
13. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
[TBL] [Abstract][Full Text] [Related]
14. [Bloodless prostate treatment using high-intensity focused ultrasound (HIFU)].
Eberle J; Böhlen D; Fügen M; Studer UE
Schweiz Med Wochenschr; 1996 Aug; 126(33):1385-92. PubMed ID: 8830396
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
Urologiia; 2007; (6):39-44. PubMed ID: 18649659
[TBL] [Abstract][Full Text] [Related]
16. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
Inoue Y; Goto K; Hayashi T; Hayashi M
Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
[TBL] [Abstract][Full Text] [Related]
17. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
[TBL] [Abstract][Full Text] [Related]
18. Transurethral incision/resection of the prostate (TUIP/TURP) in operative treatment of repeated bladder outlet obstruction early after kidney transplantation.
Mokos I; Kastelan Z; Basić-Jukić N; Kes P; Pasini J
Acta Clin Croat; 2011 Sep; 50(3):381-4. PubMed ID: 22384774
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
20. Control of prostate cancer by transrectal HIFU in 227 patients.
Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
